Related references
Note: Only part of the references are listed.β3-adrenoreceptor blockade reduces tumor growth and increases neuronal differentiation in neuroblastoma via SK2/S1P2 modulation
Gennaro Bruno et al.
ONCOGENE (2020)
β3-Adrenoreceptor Blockade Induces Stem Cells Differentiation in Melanoma Microenvironment
Maura Calvani et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Serum cytokine profiles in infants with infantile hemangiomas on oral propranolol treatment: VEGF and bFGF, potential biomarkers predicting clinical outcomes
Meerim Park et al.
PEDIATRIC RESEARCH (2020)
Clinical and radiological outcomes of infantile hemangioma treated with oral propranolol: A long-term follow-up study
Zhang Yu et al.
JOURNAL OF DERMATOLOGY (2019)
β3-Adrenoceptor as a potential immuno-suppressor agent in melanoma
Maura Calvani et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Propranolol 0.2% Eye Micro-Drops for Retinopathy of Prematurity: A Prospective Phase IIB Study
Luca Filippi et al.
FRONTIERS IN PEDIATRICS (2019)
β-Adrenoceptor Blockade for Infantile Hemangioma Therapy: Do β3-Adrenoceptors Play a Role?
Carlos E. Escarcega Gonzalez et al.
JOURNAL OF VASCULAR RESEARCH (2018)
Serum concentrations of VEGF and bFGF in the course of propranolol therapy of infantile hemangioma in children: Are we closer to understand the mechanism of action of propranolol on hemangiomas?
Lidia Babiak-Choroszczak et al.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2018)
PHACE Syndrome: Consensus-Derived Diagnosis and Care Recommendations
Maria C. Garzon et al.
JOURNAL OF PEDIATRICS (2016)
A Randomized, Controlled Trial of Oral Propranolol in Infantile Hemangioma
C. Leaute-Labreze et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular Anomalies
Michel Wassef et al.
PEDIATRICS (2015)
Infantile Hemangiomas, Retinopathy of Prematurity and Cancer: A Common Pathogenetic Role of the β-Adrenergic System
Luca Filippi et al.
MEDICINAL RESEARCH REVIEWS (2015)
Effectiveness and Safety of Oral Propranolol versus Other Treatments for Infantile Hemangiomas: A Meta-Analysis
Xiaohan Liu et al.
PLOS ONE (2015)
Norepinephrine promotes tumor microenvironment reactivity through β3-adrenoreceptors during melanoma progression
Maura Calvani et al.
ONCOTARGET (2015)
Propranolol inhibits growth of hemangioma-initiating cells but does not induce apoptosis
Jina J. Y. Kum et al.
PEDIATRIC RESEARCH (2014)
Propranolol inhibits endothelial progenitor cell homing: a possible treatment mechanism of infantile hemangioma
Hai-Xiao Zou et al.
CARDIOVASCULAR PATHOLOGY (2013)
Propranolol concentrations after oral administration in term and preterm neonates
L. Filippi et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2013)
Functional involvement of β3-adrenergic receptors in melanoma growth and vascularization
Massimo Dal Monte et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2013)
Oral Propranolol for Retinopathy of Prematurity: Risks, Safety Concerns, and Perspectives
Luca Filippi et al.
JOURNAL OF PEDIATRICS (2013)
Beta3-adrenergic receptors modulate vascular endothelial growth factor release in response to hypoxia through the nitric oxide pathway in mouse retinal explants
Massimo Dal Monte et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2013)
The role of β-adrenergic receptor signaling in the proliferation of hemangioma-derived endothelial cells
Yi Ji et al.
CELL DIVISION (2013)
Induction of apoptosis in infantile hemangioma endothelial cells by propranolol
Jun-Bo Tu et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2013)
High levels of β2-adrenoceptors are expressed in infantile capillary hemangiomas and may mediate the therapeutic effect of propranolol
Eva Hadaschik et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2012)
Effects of propranolol on the proliferation and apoptosis of hemangioma-derived endothelial cells
Yi Ji et al.
JOURNAL OF PEDIATRIC SURGERY (2012)
β-Adrenergic receptor expression in vascular tumors
Karen M. Chisholm et al.
MODERN PATHOLOGY (2012)
Propranolol treatment of infantile hemangioma endothelial cells: A molecular analysis
Jessica Stiles et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2012)
Different Efficacy of Propranolol in Mice with Oxygen-Induced Retinopathy: Could Differential Effects of Propranolol Be Related to Differences in Mouse Strains?
Luca Filippi et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)
Propranolol Inhibition of β-Adrenergic Receptor Does Not Suppress Pathologic Neovascularization in Oxygen-Induced Retinopathy
Jing Chen et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)
Hypoxia regulates the production and activity of glucose transporter-1 and indoleamine 2,3-dioxygenase in monocyte-derived endothelial-like cells: possible relevance to infantile haemangioma pathogenesis
A. Herbert et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Antiangiogenic effects of β2-adrenergic receptor blockade in a mouse model of oxygen-induced retinopathy
Davide - Martini et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Hypoxia-Inducible Factor-1α Is Essential for Hypoxia-Induced Mesenchymal Stem Cell Mobilization into the Peripheral Blood
Lizhen Liu et al.
STEM CELLS AND DEVELOPMENT (2011)
Role of the Adrenergic System in a Mouse Model of Oxygen-Induced Retinopathy: Antiangiogenic Effects of beta-Adrenoreceptor Blockade
Chiara Ristori et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
Characteristics of Infantile Hemangiomas as Clues to Pathogenesis Does Hypoxia Connect the Dots?
Beth A. Drolet et al.
ARCHIVES OF DERMATOLOGY (2010)
The selectivity of β-adrenoceptor agonists at human β1-, β2- and β3-adrenoceptors
Jillian G. Baker
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Propranolol for severe hemangiomas of infancy
Christine Leaute-Labreze et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Growth characteristics of infantile hemangiomas: Implications for management
Linda C. Chang et al.
PEDIATRICS (2008)
Hypoxia-induced mediators of stem/progenitor cell trafficking are increased in children with hemangioma
Mark E. Kleinman et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Beta adrenergic receptors in Keratinocytes
Raja K. Sivamani et al.
DERMATOLOGIC CLINICS (2007)
Placental anomalies in children with infantile hemangioma
Juan Carlos Lopez Gutierrez et al.
PEDIATRIC DERMATOLOGY (2007)
Prospective study of infantile hemangiomas: Demographic, prenatal, and perinatal characteristics
Anita N. Haggstrom et al.
JOURNAL OF PEDIATRICS (2007)
Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease
DH Walter et al.
CIRCULATION RESEARCH (2005)
Predicting inhibitory drug-drug interactions and evaluating drug interaction reports using inhibition constants
KA Bachmann et al.
ANNALS OF PHARMACOTHERAPY (2005)
Differential expression of pro- and antiangiogenic factors in mouse strain-dependent hypoxia-induced retinal neovascularization
CK Chan et al.
LABORATORY INVESTIGATION (2005)
Ipsilateral hemangioma and aortic arch anomalies in posterior fossa malformations, hemangiomas, arterial anomalies, coarctation of the aorta, and cardiac defects and eye abnormalities (PHACE) anomaly: Report and review
G Bronzetti et al.
PEDIATRICS (2004)
Comparative pharmacology of human β-adrenergic receptor subtypes -: characterization of stably transfected receptors in CHO cells
C Hoffmann et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2004)
Endothelial progenitor cells - Mobilization, differentiation, and homing
M Hristov et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Are infantile Hemangiomas of placental origin?(vol 109, pg 223, 2002)
PE North et al.
OPHTHALMOLOGY (2002)
Somatic mutation of vascular endothelial growth factor receptors in juvenile hemangioma
JW Walter et al.
GENES CHROMOSOMES & CANCER (2002)
Upregulation of functional β3-adrenergic receptor in the failing canine myocardium
HJ Cheng et al.
CIRCULATION RESEARCH (2001)
Upregulation of β2-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium
S Moniotte et al.
CIRCULATION (2001)
GLUT1: A newly discovered immunohistochemical marker for juvenile hemangiomas
PE North et al.
HUMAN PATHOLOGY (2000)
Share Paper
